期刊文献+

维生素D3抑制角质形成细胞CXCR2的表达 被引量:3

The Inhibitory Effect of Vit D3 on the Expression of CXCR2 on Keratinocytes
原文传递
导出
摘要 目的观察维生素D3对角质形成细胞表面表达CXCR2的影响,探讨其在治疗银屑病中的作用机制。方法用不同浓度的维生素D3处理人角质形成细胞株HaCaT,48h后通过四甲基偶氮唑盐(MTT)法检测了维生素D3抑制HaCaT增殖的有效剂量;通过流式细胞仪(FACS)分析维生素D3处理的HaCaT表达趋化因子受体CXCR2的情况。结果HaCaT经维生素D3在8.0×10-8mol/L~5.12×10-6mol/L浓度范围内处理48h后的A值较未处理组明显降低(P<0.05)。HaCaT在5.12×10-6mol/L维生素D3处理48h后CXCR2的表达明显低于正常对照组。结论维生素D3治疗银屑病的作用机制部分是通过抑制角质形成细胞表达CXCR2,从而达到抑制角质形成细胞增殖的目的。 Objective To detect the expression of CXCR2on p soriatic lesional keratinocytes an d to in-vestigate the mechanism of Vit D3in t he treatment of psoriasis.Methods The proliferative capacity of human keratinocyte cell line,HaCaT,trea ted with Vit D3was detected by MTT assays.The expression of CXCR2on HaCaT treated with Vit D3was assayed by FACS calibur.Results The Vit D3at proper concentrations c ould inhibit the proliferation of HaCaT and down-regulate the CXCR2expression on the cells.Conclusion One of the mechanisms for Vit D3in the treatment of psoriasis might be the inhibition of CXCR2expression on keratinocytes,which con-tributes to inhibit the over-proliferation of keratinocytes in psoriasis.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2002年第5期378-379,共2页 Chinese Journal of Dermatology
基金 国家自然科学基金(39970689) 上海市科技启明星计划资助(99QB14047)
关键词 维生素D3 胆骨化醇 角蛋白细胞 CXCR2 银屑病 药理学 Cholecalciferol Keratinocytes C XCR2
  • 相关文献

参考文献7

  • 1郑家润.抗银屑病药物治疗和研究的现状及展望[J].中华皮肤科杂志,1997,30(2):78-80. 被引量:20
  • 2Van de Kerkhof PCM. An update on vitamin D3 analogues in the treatment of psoriasis. Skin Pharmacol,1998,11:2- 10.
  • 3Gillitzer R,Ritter U,Spandau U,et aL.Differential expression of GRO alpha and IL- 8 mRNA in psoriasis:a model for neutrophil migration and accumulation in vivo. J Invest Dermatol, 1996,107:778- 782.
  • 4Nickoloff BJ. The cytokine network in psoriasis. Arch Dermatol,1991,127:871- 884.
  • 5Terui T,Ozawa M,Tagami H. Role of neutrophils in induction of acute inflammation in T cell mediated immune dermatosis,psoriasis:a neutrophil associated inflammation boosting loop. Exp Dermatol, 2000,9:1- 10.
  • 6Biasi D,Carletto A,Caramaschi P,et al.Neutrophil functions and IL- 8 in psoriatic arthritis and in cutaneous psoriasis.Inflammation, 1998,22:533- 543.
  • 7Okubo Y,Koga M. Peripheral blood monocytes in psoriatic patients overproduce cytokines. J Dermatol Sci, 1998,17:223- 232.

二级参考文献4

  • 1邵长庚.我国银屑病的流行和防治现状[J].中华皮肤科杂志,1996,29(2):75-76. 被引量:72
  • 2王贤才,临床药物大典,1994年,1458页
  • 3刘昌孝,药代动力学数据库.临床部分,1994年,456页
  • 4刘承煌,银屑病的临床和研究,1994年,238页

共引文献19

同被引文献29

  • 1李海,黎晓天,彭宇,吴文言.人趋化因子受体CCR5胞外片段的融合表达与纯化[J].免疫学杂志,2009,25(1):39-42. 被引量:1
  • 2Samson M, Labbe O, Mollereau C, et al. Molecular cloning and functional expression of a new human CC-chemokine receptor gene[J]. Biochemistry, 1996, 35(11): 3362-3367.
  • 3Loetscher P, Uguccioni M, Bordoli L, et al. CCR5 is characteristic of Th1 lymphocytes [J]. Nature, 1998, 391 (6665): 344-345.
  • 4Owens MA, Vail HG, Hurley AA, et ai. Validation and quality control of immunophenotyping in clinical flow cytometry [J]. J Immunol Methods, 2000, 243(1-2): 33-50.
  • 5Brown A J, Slatopolsky E. Vitamin D analogs: therapeutic applications and mechanisms for selectivity [J]. Mol Aspects Med, 2008, 29(6): 433-452.
  • 6Arnold V, Balkow S, Staats R, et al. Increase in perforin-positive peripheral blood lymphocytes in extrinsic and intrinsic asthma [J]. Am J Respir Crit Care Med, 2000, 161 (1): 182-186.
  • 7Abe E, Miyaura C, Sakagami H, et al. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3 [J]. Proc Natl Acad Sci USA, 1981, 78(8): 4990-4994.
  • 8Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor [J]. Endocrinology, 2006, 147(12): 5542-5548.
  • 9Campbell M J, Adorini L. The vitamin D receptor as a therapeutic target [J]. Expert Opin Ther Targets, 2006, 10 (5): 735-748.
  • 10Carlberg C, Seuter S. The vitamin D receptor [J]. Dermatol Clin, 2007, 25(4): 515-523.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部